"GLP-1 Receptor Agonists for Nonalcoholic Steatohepatitis." Hepatology, 2021
Back Mojsov, S, Weir, GC, Habener, JF (Feb 1987) 'Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas', Journal of Clinical Investigation , 79, 616-19
Why Consider Switching from Semaglutide to Tirzepatide
All GLP-1 medications follow dose-escalation protocols over 416 weeks to minimise gastrointestinal side effects such as nausea and vomiting
Retatrutide, also known as LY3437943, is a peptide-class triple agonist that activates the GIP, GLP-1, and glucagon receptors, but it is not currently FDA-approved for any indication and is not available as an approved prescription product 1, 2, 3
10.1093/cvr/cvv187 76 MeuweseC